|
US4701521A
(en)
|
1978-07-17 |
1987-10-20 |
The Trustees Of Boston University |
Method of effecting cellular uptake of molecules
|
|
US4749570A
(en)
|
1981-12-31 |
1988-06-07 |
The Governors Of The University Of Alberta |
Targeting conjugates of albumin and therapeutic agents
|
|
US4671958A
(en)
|
1982-03-09 |
1987-06-09 |
Cytogen Corporation |
Antibody conjugates for the delivery of compounds to target sites
|
|
US4867973A
(en)
|
1984-08-31 |
1989-09-19 |
Cytogen Corporation |
Antibody-therapeutic agent conjugates
|
|
JPS5936691A
(ja)
*
|
1982-08-24 |
1984-02-28 |
Rikagaku Kenkyusho |
新規オリゴマンノシド及びその製造法
|
|
US5851991A
(en)
|
1987-08-31 |
1998-12-22 |
The Regents Of The University Of California |
Therapeutic use of the retinoblastoma susceptibility gene product
|
|
US5066789A
(en)
|
1988-09-30 |
1991-11-19 |
Neorx Corporation |
Targeting substance-diagnostic/therapeutic agent conjugates having Schiff base linkages
|
|
US5549892A
(en)
|
1988-12-23 |
1996-08-27 |
Genzyme Corporation |
Enhanced in vivo uptake of glucocerebrosidase
|
|
US5236838A
(en)
|
1988-12-23 |
1993-08-17 |
Genzyme Corporation |
Enzymatically active recombinant glucocerebrosidase
|
|
IL93432A
(en)
|
1989-02-24 |
1994-02-27 |
Johnson Mathey Inc |
Hydrazines and hydrazides, their conjugates with macromolecules and such conjugates labelled with metal ions
|
|
US5206370A
(en)
|
1989-02-24 |
1993-04-27 |
Johnson Matthey, Inc. |
Certain pyridyl hydrazines and hydrazides useful for protein labeling
|
|
US5179023A
(en)
|
1989-03-24 |
1993-01-12 |
Research Corporation Technologies, Inc. |
Recombinant α-galactosidase a therapy for Fabry disease
|
|
US5212298A
(en)
|
1989-08-16 |
1993-05-18 |
Monsanto Company |
Method for producing synthetic N-linked glycoconjugates
|
|
US5280113A
(en)
|
1989-08-16 |
1994-01-18 |
Monsanto Company |
Method for producing synthetic N-linked glycoconjugates
|
|
US5324663A
(en)
|
1990-02-14 |
1994-06-28 |
The Regents Of The University Of Michigan |
Methods and products for the synthesis of oligosaccharide structures on glycoproteins, glycolipids, or as free molecules, and for the isolation of cloned genetic sequences that determine these structures
|
|
US5670488A
(en)
|
1992-12-03 |
1997-09-23 |
Genzyme Corporation |
Adenovirus vector for gene therapy
|
|
US5583042A
(en)
|
1990-04-16 |
1996-12-10 |
Neose Pharmaceuticals, Inc. |
Apparatus for the synthesis of saccharide compositions
|
|
US5312903A
(en)
*
|
1990-06-01 |
1994-05-17 |
E. I. Du Pont De Nemours And Company |
Lysine-glycosylated recombinant interleukin-2
|
|
US5677440A
(en)
|
1990-07-16 |
1997-10-14 |
Howard Florey Institute Of Experimental Physiology And Medicine |
Oligonucleotide-polyamide conjugates
|
|
US5153312A
(en)
|
1990-09-28 |
1992-10-06 |
American Cyanamid Company |
Oligosaccharide conjugate vaccines
|
|
CA2073511A1
(en)
|
1990-11-14 |
1992-05-29 |
Matthew R. Callstrom |
Conjugates of poly(vinylsaccharide) with proteins for the stabilization of proteins
|
|
AU1676992A
(en)
|
1991-03-18 |
1992-10-21 |
Enzon, Inc. |
Hydrazine containing conjugates of polypeptides and glycopolypeptides with polymers
|
|
US5968502A
(en)
|
1991-11-05 |
1999-10-19 |
Transkaryotic Therapies, Inc. |
Protein production and protein delivery
|
|
DE10399015I1
(de)
*
|
1991-12-20 |
2012-05-03 |
Novo Nordisk As |
Stabilisierte pharmazeutische formulierung, die wachstumshormon und histidin enthält
|
|
US5834266A
(en)
|
1993-02-12 |
1998-11-10 |
President & Fellows Of Harvard College |
Regulated apoptosis
|
|
US6372716B1
(en)
*
|
1994-04-26 |
2002-04-16 |
Genetics Institute, Inc. |
Formulations for factor IX
|
|
FR2721612B1
(fr)
|
1994-06-23 |
1996-08-09 |
Idm |
Nouveaux dérivés d'oligosides, leur procédé de préparation et leurs applications.
|
|
US6132764A
(en)
|
1994-08-05 |
2000-10-17 |
Targesome, Inc. |
Targeted polymerized liposome diagnostic and treatment agents
|
|
US5719131A
(en)
|
1994-12-09 |
1998-02-17 |
Genzyme Corporation |
Cationic amphiphiles containing dialkylamine lipophilic groups for intracellular delivery of therapeutic molecules
|
|
US5910487A
(en)
|
1994-12-09 |
1999-06-08 |
Genzyme Corporation |
Cationic amphiphiles and plasmids for intracellular delivery of therapeutic molecules
|
|
US5767099A
(en)
|
1994-12-09 |
1998-06-16 |
Genzyme Corporation |
Cationic amphiphiles containing amino acid or dervatized amino acid groups for intracellular delivery of therapeutic molecules
|
|
US5939401A
(en)
|
1994-12-09 |
1999-08-17 |
Genzyme Corporation |
Cationic amphiphile compositions for intracellular delivery of therapeutic molecules
|
|
US6071890A
(en)
|
1994-12-09 |
2000-06-06 |
Genzyme Corporation |
Organ-specific targeting of cationic amphiphile/DNA complexes for gene therapy
|
|
US5650096A
(en)
|
1994-12-09 |
1997-07-22 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
|
US5840710A
(en)
|
1994-12-09 |
1998-11-24 |
Genzyme Corporation |
Cationic amphiphiles containing ester or ether-linked lipophilic groups for intracellular delivery of therapeutic molecules
|
|
US5747471A
(en)
|
1994-12-09 |
1998-05-05 |
Genzyme Corporation |
Cationic amphiphiles containing steroid lipophilic groups for intracellular delivery of therapeutic molecules
|
|
US5948767A
(en)
|
1994-12-09 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphile/DNA complexes
|
|
US6492332B1
(en)
|
1995-12-12 |
2002-12-10 |
Omeros Corporation |
Irrigation solution and methods for inhibition of tumor cell adhesion, pain and inflammation
|
|
US5811510A
(en)
|
1995-04-14 |
1998-09-22 |
General Hospital Corporation |
Biodegradable polyacetal polymers and methods for their formation and use
|
|
US6118045A
(en)
|
1995-08-02 |
2000-09-12 |
Pharming B.V. |
Lysosomal proteins produced in the milk of transgenic animals
|
|
JPH11514853A
(ja)
|
1995-09-08 |
1999-12-21 |
ジエンザイム コーポレイション |
遺伝子治療のための改良されたａａｖベクター
|
|
US5916911A
(en)
|
1995-09-20 |
1999-06-29 |
The Regents Of The University Of Michigan |
Amino ceramide--like compounds and therapeutic methods of use
|
|
US7141676B1
(en)
|
1996-02-08 |
2006-11-28 |
University Of Washington |
Water soluble multi-biotin-containing compounds
|
|
JP2000507246A
(ja)
*
|
1996-03-21 |
2000-06-13 |
トランセル テクノロジーズ インク． |
固体相のリポグリコペプチドライブラリー、組成物及び方法
|
|
US5840702A
(en)
|
1996-03-22 |
1998-11-24 |
Uab Research Foundation |
Cystic fibrosis treatment
|
|
US5935936A
(en)
|
1996-06-03 |
1999-08-10 |
Genzyme Corporation |
Compositions comprising cationic amphiphiles and co-lipids for intracellular delivery of therapeutic molecules
|
|
AUPO190596A0
(en)
|
1996-08-26 |
1996-09-19 |
Alchemia Pty Ltd |
Oligosaccharide synthesis
|
|
NZ506214A
(en)
|
1996-09-13 |
2002-11-26 |
Transkaryotic Therapies Inc |
Therapy for alpha-galactosidase A deficiency
|
|
US5861397A
(en)
|
1996-10-03 |
1999-01-19 |
Vical Incorporated |
Piperazine based cytofectins
|
|
NZ331578A
(en)
|
1997-01-21 |
2000-05-26 |
Pasteur Merieux Serums Vacc |
Polysaccharide-peptide-conjugates
|
|
US5925628A
(en)
|
1997-03-31 |
1999-07-20 |
Genzyme Corporation |
Cationic amphiphiles for intracellular delivery of therapeutic molecules
|
|
US5912239A
(en)
|
1997-04-04 |
1999-06-15 |
Genzyme Corporation |
Imidazole-containing cationic amphiphiles for intracellular delivery of therapeutic molecules
|
|
US5948925A
(en)
|
1997-05-06 |
1999-09-07 |
Genzyme Corporation |
Cationic amphiphiles containing linkers derived from neutral or positively charged amino acids
|
|
US5952516A
(en)
|
1997-05-08 |
1999-09-14 |
Genzyme Corporation |
Cationic amphiphiles containing multiplesteroid lipophilic groups
|
|
US5942634A
(en)
|
1997-05-09 |
1999-08-24 |
Genzyme Corporation |
Cationic amphiphiles for cell transfections
|
|
EP1027069B1
(en)
|
1997-10-29 |
2006-07-26 |
Genzyme Corporation |
Gene therapy for gaucher disease
|
|
SE513149C2
(sv)
|
1997-12-05 |
2000-07-17 |
Katarina Edwards |
Läkemedelsdistributionssystem med tvåstegsmålsökning, till specifika celler eller vävnad och till dess cellkärna
|
|
US6465488B1
(en)
|
1997-12-11 |
2002-10-15 |
Chancellor, Masters & Scholars Of The University Of Oxford |
Inhibition of glycolipid biosynthesis
|
|
US6703488B1
(en)
|
1998-01-15 |
2004-03-09 |
Center For Molecular Medicine And Immunology |
Antibody/receptor targeting moiety for enhanced delivery of armed ligand
|
|
US6287857B1
(en)
|
1998-02-09 |
2001-09-11 |
Genzyme Corporation |
Nucleic acid delivery vehicles
|
|
JP2002505085A
(ja)
|
1998-02-17 |
2002-02-19 |
ジェンザイム・コーポレイション |
精製ａａｖベクターの生産方法
|
|
CA2318737A1
(en)
|
1998-02-17 |
1999-08-19 |
Genzyme Corporation |
Methods for pseudoadenoviral vector production
|
|
US6537520B1
(en)
|
1998-03-31 |
2003-03-25 |
Bristol-Myers Squibb Pharma Company |
Pharmaceuticals for the imaging of angiogenic disorders
|
|
WO1999057296A1
(en)
|
1998-05-01 |
1999-11-11 |
Genzyme Corporation |
Partially deleted adenoviral vectors
|
|
US6362371B1
(en)
|
1998-06-08 |
2002-03-26 |
Advanced Medicine, Inc. |
β2- adrenergic receptor agonists
|
|
US6538117B1
(en)
|
1999-08-10 |
2003-03-25 |
The Scripps Research Institute |
Programmable one-pot oligosaccharide synthesis
|
|
US6399575B1
(en)
|
1998-11-10 |
2002-06-04 |
Auburn University |
Methods and compositions for targeting compounds to the central nervous system
|
|
US6610703B1
(en)
|
1998-12-10 |
2003-08-26 |
G.D. Searle & Co. |
Method for treatment of glycolipid storage diseases
|
|
GB0100889D0
(en)
|
2001-01-12 |
2001-02-21 |
Oxford Glycosciences Uk Ltd |
Compounds
|
|
GB9909064D0
(en)
|
1999-04-20 |
1999-06-16 |
Oxford Glycosciences Uk Ltd |
Therapies
|
|
GB9909066D0
(en)
|
1999-04-20 |
1999-06-16 |
Oxford Glycosciences Uk Ltd |
Therapies
|
|
JP2003505430A
(ja)
|
1999-07-26 |
2003-02-12 |
ジー・ディー・サール・アンド・カンパニー |
デオキシノジリマイシンの長鎖ｎ−アルキル誘導体およびグルコセレブロシダーゼ酵素の糖脂質異常蓄積疾患の治療用の薬剤の製造のための使用
|
|
US6534300B1
(en)
|
1999-09-14 |
2003-03-18 |
Genzyme Glycobiology Research Institute, Inc. |
Methods for producing highly phosphorylated lysosomal hydrolases
|
|
US6770468B1
(en)
|
1999-09-14 |
2004-08-03 |
Genzyme Glycobiology Research Institute, Inc. |
Phosphodiester-α-GlcNAcase of the lysosomal targeting pathway
|
|
WO2001036620A2
(en)
|
1999-11-16 |
2001-05-25 |
Genzyme Corporation |
Vectors and transgenies with regulatory elements for gene delivery to the liver
|
|
US6749865B2
(en)
|
2000-02-15 |
2004-06-15 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
|
EP1263472A2
(en)
|
2000-02-15 |
2002-12-11 |
Genzyme Corporation |
Modification of biopolymers for improved drug delivery
|
|
US20010031741A1
(en)
|
2000-02-17 |
2001-10-18 |
Robin Ziegler |
Methods for treatment of lysosomal storage diseases
|
|
CA2441903C
(en)
|
2000-05-26 |
2012-07-31 |
National Research Council Of Canada |
Single-domain brain-targeting antibody fragments derived from llama antibodies
|
|
US20040014652A1
(en)
|
2000-06-01 |
2004-01-22 |
Andre Trouet |
Tumor activated prodrug compounds and methods of making and using the same
|
|
US20020095135A1
(en)
|
2000-06-19 |
2002-07-18 |
David Meeker |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20040204379A1
(en)
|
2000-06-19 |
2004-10-14 |
Cheng Seng H. |
Combination enzyme replacement, gene therapy and small molecule therapy for lysosomal storage diseases
|
|
US20040067527A1
(en)
|
2000-07-26 |
2004-04-08 |
Sara Lavi |
Intracellular delivery system for protein phosphatases and other polypeptides
|
|
DE60110094T2
(de)
|
2000-08-18 |
2009-10-01 |
Massachusetts Institute Of Technology, Cambridge |
Vorrichtung und verfahren zur automatisierten synthese von oligosacchariden
|
|
US6676963B1
(en)
|
2000-10-27 |
2004-01-13 |
Barnes-Jewish Hospital |
Ligand-targeted emulsions carrying bioactive agents
|
|
US7001994B2
(en)
|
2001-01-18 |
2006-02-21 |
Genzyme Corporation |
Methods for introducing mannose 6-phosphate and other oligosaccharides onto glycoproteins
|
|
US7723296B2
(en)
|
2001-01-18 |
2010-05-25 |
Genzyme Corporation |
Methods for introducing mannose-6-phosphate and other oligosaccharides onto glycoproteins and its application thereof
|
|
US7629309B2
(en)
|
2002-05-29 |
2009-12-08 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
|
EP1436316B1
(en)
|
2001-04-30 |
2008-01-23 |
ZyStor Therapeutics , Inc. |
Subcellular targeting of therapeutic proteins
|
|
US7560424B2
(en)
|
2001-04-30 |
2009-07-14 |
Zystor Therapeutics, Inc. |
Targeted therapeutic proteins
|
|
JP2004514410A
(ja)
|
2001-05-07 |
2004-05-20 |
スプラテック ファーマ インコーポレイティド |
生物剤の経口およびｃｎｓ供給を強化するためのリガンド
|
|
US6855830B2
(en)
|
2001-07-16 |
2005-02-15 |
Genzyme Corporation |
Synthesis of UDP-glucose: N-acylsphingosine glucosyltransferase inhibitors
|
|
EP2292273A3
(en)
|
2001-10-10 |
2011-11-23 |
BioGeneriX AG |
Remodeling and glycoconjugation of peptides
|
|
US7265084B2
(en)
|
2001-10-10 |
2007-09-04 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
|
WO2003045928A1
(en)
|
2001-11-26 |
2003-06-05 |
Genzyme Corporation |
Diastereoselective synthesis of udp-glucose : n-acylsphingosine glucosyltransferase inhibitors
|
|
JP2005535280A
(ja)
*
|
2001-11-28 |
2005-11-24 |
ネオーズ テクノロジーズ， インコーポレイテッド |
エンドグリカナーゼを用いる糖タンパク質のリモデリング
|
|
US6905856B2
(en)
|
2001-12-21 |
2005-06-14 |
Genzyme Glycobiology Research Institute, Inc. |
Soluble GlcNAc phosphotransferase
|
|
US6800472B2
(en)
|
2001-12-21 |
2004-10-05 |
Genzyme Glycobiology Research Institute, Inc. |
Expression of lysosomal hydrolase in cells expressing pro-N-acetylglucosamine-1-phosphodiester α-N-acetyl glucosimanidase
|
|
WO2003057179A2
(en)
|
2002-01-11 |
2003-07-17 |
Biomarin Pharmaceutical, Inc. |
Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
|
|
WO2003070823A2
(en)
|
2002-02-20 |
2003-08-28 |
The General Hospital Corporation |
Conjugates comprising a biodegradable polymer and uses therefor
|
|
US6916802B2
(en)
|
2002-04-29 |
2005-07-12 |
Genzyme Corporation |
Amino ceramide-like compounds and therapeutic methods of use
|
|
JP5589165B2
(ja)
|
2003-01-31 |
2014-09-17 |
マウント シナイ スクール オブ メディシン オブ ニューヨーク ユニバーシティー |
タンパク質欠損性障害の治療のための併用療法
|
|
WO2005002515A2
(en)
|
2003-06-20 |
2005-01-13 |
Biomarin Pharmaceutical Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
|
US20050026823A1
(en)
|
2003-06-20 |
2005-02-03 |
Biomarin Pharmaceutical Inc. |
Use of the chaperone receptor-associated protein (RAP) for the delivery of therapeutic compounds to the brain and other tissues
|
|
WO2005014035A2
(en)
|
2003-08-08 |
2005-02-17 |
Novo Nordisk Health Care Ag |
Use of galactose oxidase for selective chemical conjugation of protractor molecules to proteins of therapeutic interest
|
|
ES2294535T3
(es)
|
2003-08-12 |
2008-04-01 |
Lipoxen Technologies Limited |
Derivados del acido polisialico.
|
|
US7442372B2
(en)
|
2003-08-29 |
2008-10-28 |
Biomarin Pharmaceutical Inc. |
Delivery of therapeutic compounds to the brain and other tissues
|
|
US7232805B2
(en)
|
2003-09-10 |
2007-06-19 |
Inflabloc Pharmaceuticals, Inc. |
Cobalamin conjugates for anti-tumor therapy
|
|
EP1525890A1
(en)
|
2003-10-02 |
2005-04-27 |
Complex Biosystems GmbH |
Protein-Proteophore complexes
|
|
US7176185B2
(en)
|
2003-11-25 |
2007-02-13 |
Tsrl, Inc. |
Short peptide carrier system for cellular delivery of agent
|
|
CA2556169C
(en)
|
2004-01-29 |
2011-11-22 |
Andrew Lees |
Use of amino-oxy functional groups in the preparation of vaccines
|
|
US20080014188A1
(en)
|
2004-02-06 |
2008-01-17 |
Zankel Todd C |
Manufacture of Highly Phosphorylated Lysosomal Enzymes and Uses Thereof
|
|
PL1740204T3
(pl)
|
2004-04-01 |
2018-08-31 |
Chiesi Farmaceutici S.P.A. |
Lecznicze zastosowanie alfa-mannozydazy
|
|
US8017151B2
(en)
|
2004-09-07 |
2011-09-13 |
Board Of Regents Of The University Of Nebraska By And Behalf Of The University Of Nebraska Medical Center |
Amphiphilic polymer-protein conjugates and methods of use thereof
|
|
JP5137814B2
(ja)
|
2005-04-06 |
2013-02-06 |
ジェンザイム・コーポレーション |
治療ターゲティングのための酸不安定リンカーを介するｐｅｇおよびポリシアルリソソーム酵素のコンジュゲート
|
|
AR059089A1
(es)
*
|
2006-01-20 |
2008-03-12 |
Genzyme Corp |
Administracion intraventricular de una enzima para enfermedades de almacenamiento lisosomal
|
|
US20070249014A1
(en)
*
|
2006-02-10 |
2007-10-25 |
Invitrogen Corporation |
Labeling and detection of post translationally modified proteins
|
|
US9283260B2
(en)
*
|
2006-04-21 |
2016-03-15 |
Amgen Inc. |
Lyophilized therapeutic peptibody formulations
|
|
WO2008089339A2
(en)
|
2007-01-18 |
2008-07-24 |
Genzyme Corporation |
Oligosaccharide conjugates for cellular targeting
|
|
CN102978185B
(zh)
|
2007-01-18 |
2015-02-11 |
建新公司 |
包含氨基氧基基团的寡糖及其轭合物
|
|
EP3608330B1
(en)
|
2008-12-16 |
2022-11-09 |
Genzyme Corporation |
Synthetic intermediates for preparing oligosaccharide-protein conjugates
|
|
US12285108B1
(en)
|
2024-08-08 |
2025-04-29 |
Frank R. Connors |
Shelf device with interchangeable faceplate
|